Shopping Cart
- Remove All
- Your shopping cart is currently empty
Glycogen phosphorylase-IN-1 is a selective and potent inhibitor of human hepatic glycogen phosphorylase (hlGPa) with inhibitory effects on hlGPa activity and on hepatocyte glycogen-derived glucose production, and can be used in the study of type 2 diabetes mellitus and canine lupus.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $229 | In Stock | |
5 mg | $688 | In Stock | |
10 mg | $983 | In Stock | |
25 mg | $1,460 | In Stock | |
50 mg | $1,960 | In Stock | |
100 mg | $2,650 | In Stock |
Description | Glycogen phosphorylase-IN-1 is a selective and potent inhibitor of human hepatic glycogen phosphorylase (hlGPa) with inhibitory effects on hlGPa activity and on hepatocyte glycogen-derived glucose production, and can be used in the study of type 2 diabetes mellitus and canine lupus. |
In vivo | In the glucagon-stimulated hyperglycemia model in Wistar rats, Glycogen phosphorylase-IN-1 (5 mg/kg; administered via intravenous injection, single dose) was able to reduce blood glucose levels[1]. |
Molecular Weight | 412.78 |
Formula | C17H15ClF2N4O4 |
Cas No. | 648926-15-2 |
Smiles | O=C(NC(=O)C1=CC(F)=C(F)C=C1Cl)NC2=CC(=CC=C2OC)NC(=O)NC |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
Solubility Information | DMF: 2 mg/mL (4.85 mM), Sonication is recommended. DMSO: 2 mg/mL (4.85 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
DMF/DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.